🇺🇸 FDA
Pipeline program

SHR1459 tablet

SHR1459-I-110

Phase 1 small_molecule completed

Quick answer

SHR1459 tablet for B-cell Tumors is a Phase 1 program (small_molecule) at Jian Li with 1 ClinicalTrials.gov record(s).

Program details

Company
Jian Li
Indication
B-cell Tumors
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials